2016
DOI: 10.1097/mat.0000000000000345
|View full text |Cite
|
Sign up to set email alerts
|

Blood Product Utilization with Left Ventricular Assist Device Implantation: A Decade of Statewide Data

Abstract: Blood transfusion rates with cardiac surgery over time have decreased, this trend has not been examined for patients undergoing left ventricular assist device (LVAD) implantation. We investigated blood transfusion trends with LVAD implantation in a statewide database. Between July 2004 and June 2014, 666 LVADs were implanted (age 54.5 ± 12.6 years. 77% men). Reoperation for bleeding was required in 22% of cases. Postoperative mortality was 13.2%. Over the decade, use of any blood products with LVAD surgery by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 29 publications
0
9
0
Order By: Relevance
“…Despite the critical necessity of blood transfusion for various conditions, there is increasing evidence of morbidity and mortality associated with blood transfusion, especially in larger volumes. [5][6][7][8][9][10][11][12][13][14] In recent years, the rate of blood product administration has overall increased in cardiac surgery despite the effort to reduce blood transfusions. 2,3 In fact, nearly 90% of patients undergoing LVAD implantation require perioperative blood product transfusions.…”
Section: Commentmentioning
confidence: 99%
See 4 more Smart Citations
“…Despite the critical necessity of blood transfusion for various conditions, there is increasing evidence of morbidity and mortality associated with blood transfusion, especially in larger volumes. [5][6][7][8][9][10][11][12][13][14] In recent years, the rate of blood product administration has overall increased in cardiac surgery despite the effort to reduce blood transfusions. 2,3 In fact, nearly 90% of patients undergoing LVAD implantation require perioperative blood product transfusions.…”
Section: Commentmentioning
confidence: 99%
“…In recent years, the rate of blood product administration has overall increased in cardiac surgery despite the effort to reduce blood transfusions 2,3 . In fact, nearly 90% of patients undergoing LVAD implantation require perioperative blood product transfusions 14 . Although the impact of large volume transfusion in coronary revascularization and cardiac valve operation has been well studied, 5–10 there is a paucity of literature evaluating the impact of early massive transfusion on patients undergoing LVAD implantation.…”
Section: Commentmentioning
confidence: 99%
See 3 more Smart Citations